Equities researchers at StockNews.com began coverage on shares of Cytosorbents (NASDAQ:CTSO – Get Free Report) in a research note issued to investors on Thursday. The firm set a "hold" rating on the medical research company's stock.
Several other research analysts have also commented on the…
